Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Forrest

Showing results (101-110 of 177) with videos related to

Pageof 18
Sort By:
Antimicrobial Agents and Chemotherapy|November 14, 2012
Population pharmacokinetics of fusidic acid: rationale for front-loaded dosing regimens due to autoinhibition of clearanceJürgen B Bulitta, Olanrewaju O Okusanya, Alan Forrest, et al.
Data in Brief|March 10, 2017
Insulin secretagogue use and circulating inflammatory C-C chemokine levels in breast cancer patientsZachary A P Wintrob, Jeffrey P Hammel, George K Nimako, et al.
Expert Opinion on Drug Metabolism & Toxicology|July 26, 2006
Pharmacokinetic drug interactions with non-nucleoside reverse transcriptase inhibitorsQing Ma, Olanrewaju O Okusanya, Patrick F Smith, et al.
Antimicrobial Agents and Chemotherapy|June 1, 2017
Aerosolized Polymyxin B for Treatment of Respiratory Tract Infections: Determination of Pharmacokinetic-Pharmacodynamic Indices for Aerosolized Polymyxin B against Pseudomonas aeruginosa in a Mouse Lung Infection ModelYu-Wei Lin, Qi Zhou, Nikolas J Onufrak, et al.
Antimicrobial Agents and Chemotherapy|August 16, 2017
Pulmonary Pharmacokinetics of Colistin following Administration of Dry Powder Aerosols in RatsYu-Wei Lin, Qi Tony Zhou, Yang Hu, et al.
Antimicrobial Agents and Chemotherapy|September 13, 2017
Pharmacokinetic/Toxicodynamic Analysis of Colistin-Associated Acute Kidney Injury in Critically Ill PatientsAlan Forrest, Samira M Garonzik, Visanu Thamlikitkul, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Reply to Corona and CattaneoRoger L Nation, Samira M Garonzik, Visanu Thamlikitkul, et al.
Clinical Pharmacokinetics|January 7, 2005
Population pharmacokinetics of delavirdine and N-delavirdine in HIV-infected individualsPatrick F Smith, Robert Dicenzo, Alan Forrest, et al.
American Journal of Pharmaceutical Education|September 6, 2018
Challenges and Solutions for Future Pharmacy Practice in the Era of Precision MedicineOlivia M Dong, Rachel M Howard, Rachel Church, et al.
Diagnostic Microbiology and Infectious Disease|April 26, 2011
Evaluation of the pharmacokinetics-pharmacodynamics of fusidic acid against Staphylococcus aureus and Streptococcus pyogenes using in vitro infection models: implications for dose selectionOlanrewaju O Okusanya, Brian T Tsuji, Jurgen B Bülitta, et al.
Pageof 18

Showing results (101-110 of 177) with videos related to

Sort By:
Pageof 18
Antimicrobial Agents and Chemotherapy|November 14, 2012
Population pharmacokinetics of fusidic acid: rationale for front-loaded dosing regimens due to autoinhibition of clearanceJürgen B Bulitta, Olanrewaju O Okusanya, Alan Forrest, et al.
Data in Brief|March 10, 2017
Insulin secretagogue use and circulating inflammatory C-C chemokine levels in breast cancer patientsZachary A P Wintrob, Jeffrey P Hammel, George K Nimako, et al.
Expert Opinion on Drug Metabolism & Toxicology|July 26, 2006
Pharmacokinetic drug interactions with non-nucleoside reverse transcriptase inhibitorsQing Ma, Olanrewaju O Okusanya, Patrick F Smith, et al.
Antimicrobial Agents and Chemotherapy|June 1, 2017
Aerosolized Polymyxin B for Treatment of Respiratory Tract Infections: Determination of Pharmacokinetic-Pharmacodynamic Indices for Aerosolized Polymyxin B against Pseudomonas aeruginosa in a Mouse Lung Infection ModelYu-Wei Lin, Qi Zhou, Nikolas J Onufrak, et al.
Antimicrobial Agents and Chemotherapy|August 16, 2017
Pulmonary Pharmacokinetics of Colistin following Administration of Dry Powder Aerosols in RatsYu-Wei Lin, Qi Tony Zhou, Yang Hu, et al.
Antimicrobial Agents and Chemotherapy|September 13, 2017
Pharmacokinetic/Toxicodynamic Analysis of Colistin-Associated Acute Kidney Injury in Critically Ill PatientsAlan Forrest, Samira M Garonzik, Visanu Thamlikitkul, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Reply to Corona and CattaneoRoger L Nation, Samira M Garonzik, Visanu Thamlikitkul, et al.
Clinical Pharmacokinetics|January 7, 2005
Population pharmacokinetics of delavirdine and N-delavirdine in HIV-infected individualsPatrick F Smith, Robert Dicenzo, Alan Forrest, et al.
American Journal of Pharmaceutical Education|September 6, 2018
Challenges and Solutions for Future Pharmacy Practice in the Era of Precision MedicineOlivia M Dong, Rachel M Howard, Rachel Church, et al.
Diagnostic Microbiology and Infectious Disease|April 26, 2011
Evaluation of the pharmacokinetics-pharmacodynamics of fusidic acid against Staphylococcus aureus and Streptococcus pyogenes using in vitro infection models: implications for dose selectionOlanrewaju O Okusanya, Brian T Tsuji, Jurgen B Bülitta, et al.
Pageof 18